Feedback / Questions
AJ1-11095 - Ajax Therap
https://www.globenewswire.com/news-release/2025/12/10/3203086/0/en/Ajax-Therapeutics-Receives-Orphan-Drug-Designation-from-the-U-S-FDA-for-AJ1-11095-for-the-Treatment-of-Myelofibrosis.html
Dec 10, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next